Leerink Swann Upgrades Qiagen NV (QGEN) to Outperform; Downside Relatively Priced In
Tweet
Share
E-mailGet Alerts QGEN Hot Sheet
Price: $42.95 -0.65%
Rating Summary:
14 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
14 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Leerink Swann upgraded Qiagen NV (NASDAQ: QGEN) from Market Perform to Outperform with a price target range of $18-$20.00.
Leerink analyst says, "We are upgrading QGEN with a view that macro and company-specific concerns are priced into the stock, while the company has a few soft catalysts that could enable relative multiple expansion over the next 12 months. Potential positive catalysts include QIAsymphony uptake and regulatory approvals."
For more ratings news on Qiagen NV click here and for the rating history of Qiagen NV click here.
Shares of Qiagen NV closed at $14.11 yesterday.
Leerink analyst says, "We are upgrading QGEN with a view that macro and company-specific concerns are priced into the stock, while the company has a few soft catalysts that could enable relative multiple expansion over the next 12 months. Potential positive catalysts include QIAsymphony uptake and regulatory approvals."
For more ratings news on Qiagen NV click here and for the rating history of Qiagen NV click here.
Shares of Qiagen NV closed at $14.11 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA clears Qiagen bloodstream infection panel for U.S. market
- JPMorgan Upgrades FOX Corp. (FOXA) to Overweight
- Desjardins Upgrades PRO REIT (PRV-U:CN) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
